Aurinia Pharmaceuticals Inc
AUPH •
Buy Open
Signal type
Buy
Status
Open
Open Price
$15.59
Stop Loss
$14.81
Performance
3.08%
Days Open
14
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 1, 2026
Open Price $15.59
Stop Loss $14.81
Timespan Day
Company Profile
Name Aurinia Pharmaceuticals Inc
Ticker AUPH
Market Cap $1.01B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $16.07
List Date Oct 21, 2009
Description
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Website Open Company Website